Home
>
National Drug Code (NDC)
>
ADRUCIL
ADRUCIL - 0703-3019-12 - (fluorouracil)
Drug Information of ADRUCIL
| Product NDC: | 0703-3019 |
| Proprietary Name: | ADRUCIL |
| Non Proprietary Name: | fluorouracil |
| Active Ingredient(s): | 5 g/100mL & nbsp; fluorouracil |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ADRUCIL
| Product NDC: | 0703-3019 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040334 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20031001 |
Package Information of ADRUCIL
| Package NDC: | 0703-3019-12 |
| Package Description: | 5 VIAL in 1 TRAY (0703-3019-12) > 100 mL in 1 VIAL (0703-3019-11) |
NDC Information of ADRUCIL
| NDC Code | 0703-3019-12 |
| Proprietary Name | ADRUCIL |
| Package Description | 5 VIAL in 1 TRAY (0703-3019-12) > 100 mL in 1 VIAL (0703-3019-11) |
| Product NDC | 0703-3019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluorouracil |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20031001 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | FLUOROURACIL |
| Strength Number | 5 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
